Journal of Personalized Medicine | New Section “Life-Stage-Specific Medicine (LSSM)” Established

The Journal of Personalized Medicine (JPM, ISSN: 2075-4426) editorial team is pleased to announce the launch of a new Section, “Life-Stage-Specific Medicine (LSSM)”. The aim of this Section is to offer a platform for researchers and professionals in the field of personalized medicine on which they can demonstrate the influence of genetic and environmental factors on different life stages, in addition to how different life stages affect disease development, treatments, and longevity.

Topics could include, but are not limited to, the following:

Disease development of different life stages and responses to disease treatments;
Hormone levels in different life stages and their impact on disease development and treatments;
The immune system at different life stages and its relationship with disease development, drugs, and disease treatments;
Changes in hormone levels and immune statements during translations of life stages;
How the length of life stages affects the total lifespan of humans;
Clinical practice, clinical trials, and drug dosages with regard to the principal law of lifespan (PLOSP);
Racial and sex differences in terms of life stages and lifespan;
Menopause; puberty; and reproduction.

We are currently recruiting Editorial Board Members (EBMs) for this Section. If you are an active researcher in this field and are passionate about publishing cutting-edge research, please contact us at jpm@mdpi.com. Alternatively, you may wish to submit your work directly via the following link: https://susy.mdpi.com/user/manuscripts/upload/786489cd3ae44f21e922b7fa879d33fc?form%5Bjournal_id%5D=65.

JPM Editorial Office